{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:04:10Z","timestamp":1789747450412,"version":"4.0.1"},"reference-count":8,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>This is a retrospective study in New Zealand reviewing the incidence of topical steroid withdrawal syndrome (TSW) and other adverse effects related to topical corticosteroid (TCS) use in vulval lichen sclerosus (VLS). No patients experienced TSW and the majority of patients did not experience any adverse effects. There is insufficient evidence to conclude that TSW is a potential adverse effect of long-term TCS use for VLS.<\/jats:p>","DOI":"10.1093\/bjd\/ljag362","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:46:11Z","timestamp":1787831171000},"source":"Crossref","is-referenced-by-count":0,"title":["Topical steroid withdrawal syndrome and adverse effects of topical corticosteroids in vulval lichen sclerosus: a\u00a0single-centre retrospective study in New Zealand"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6567-0932","authenticated-orcid":false,"given":"George","family":"Yang","sequence":"first","affiliation":[{"name":"Faculty of Medical and Health Sciences, University of Auckland , Auckland ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9576-7898","authenticated-orcid":false,"given":"Hyun Kyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Waikato Hospital, Health New Zealand | Te Whatu Ora , Hamilton ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4501-2211","authenticated-orcid":false,"given":"Harriet","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Faculty of Medical and Health Sciences, University of Auckland , Auckland ,","place":["New Zealand"]},{"name":"Department of Dermatology, Te Toka Tumai Auckland City Hospital, Health New Zealand | Te Whatu Ora , Auckland ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026091811165558400_ljag362-B1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/ajd.13594","article-title":"Vulval lichen sclerosus: an Australasian management consensus","volume":"62","author":"Yeon","year":"2021","journal-title":"Australas J Dermatol"},{"key":"2026091811165558400_ljag362-B2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/LGT.0000000000000753","article-title":"Steroid phobia in patients with vulvar lichen sclerosus","volume":"27","author":"Delpero","year":"2023","journal-title":"J Low Genit Tract Dis"},{"key":"2026091811165558400_ljag362-B3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2014.11.024","article-title":"A systematic review of topical corticosteroid withdrawal (\u2018steroid addiction\u2019) in patients with atopic dermatitis and other dermatoses","volume":"72","author":"Hajar","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2026091811165558400_ljag362-B4","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/bjd\/ljaf518","article-title":"Topical steroid withdrawal syndrome: developing diagnostic criteria through a modified Delphi method","volume":"194","author":"Hsu","year":"2026","journal-title":"Br J Dermatol"},{"key":"2026091811165558400_ljag362-B5","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jid.2024.11.026","article-title":"Topical steroid withdrawal is a targetable excess of mitochondrial NAD+","volume":"145","author":"Shobnam","year":"2025","journal-title":"J Invest Dermatol"},{"key":"2026091811165558400_ljag362-B6","volume-title":"Topical Steroid Withdrawal (Red Skin Syndrome)","author":"Mohta","year":"2026"},{"key":"2026091811165558400_ljag362-B7","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1016\/j.jid.2025.05.026","article-title":"Molecular and cellular mechanisms leading to topical steroid withdrawal syndrome remain unexplained and warrant further research","volume":"145","author":"Brown","year":"2025","journal-title":"J Invest Dermatol"},{"key":"2026091811165558400_ljag362-B8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2020.05.113","article-title":"Red scrotum syndrome: an update on clinicopathologic features, pathogenesis, diagnosis, and management","volume":"87","author":"Khalil","year":"2022","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag362\/70818356\/ljag362.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag362\/70818356\/ljag362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:17:05Z","timestamp":1789744625000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article\/doi\/10.1093\/bjd\/ljag362\/8771731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":8,"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljag362","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"ljag362"}}